Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2025-12-24 @ 2:55 PM
NCT ID:
NCT05602259
Eligibility Criteria:
Inclusion Criteria:
* o All stages of NSCLC
* Stage III-IV NSCLC eligible for ICI treatment
* 18 years or older; non pregnant women
* in stage III-IV: no previous ICI and before ICI (mono- or combination therapy) initiation
* Signed informed consent
* Clinical, biological and radiological evaluation at the CHU de Liège for at least 6 months following treatment initiation
Exclusion Criteria:
* Probable noncompliance with the follow-up requirements of the study (psychiatric condition, socio-economic factors)
* Inclusion in a clinical study contraindicating the enrolment in the PROTEON study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05602259
Study Brief:
Protocol Section:
NCT05602259